We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Based Tool Accelerates Detection of Kidney Cancer

By HospiMedica International staff writers
Posted on 26 Dec 2025

Diagnosing kidney cancer depends on computed tomography scans, often using contrast agents to reveal abnormalities in kidney structure. More...

Tumors are not always searched for deliberately, as many scans are performed for unrelated reasons such as trauma or abdominal pain, increasing the risk that early cancers are missed. At the same time, radiology faces a global shortage of specialists while imaging volumes continue to rise, placing growing pressure on already overstretched clinicians. Now, researchers have validated an artificial intelligence (AI) tool that supports radiologists by accelerating kidney cancer detection and improving consistency in image interpretation.

The machine-learning-based system, developed at the University of Tartu Institute of Computer Science (Tartu, Estonia), in collaboration with engineers from Better Medicine (Tartu, Estonia), is designed to assist radiologists in analyzing abdominal CT scans and identifying kidney lesions more efficiently. The tool, called BMVision, analyses CT images and highlights both malignant and benign kidney lesions. It is designed to function as a supportive second reader, helping clinicians interpret complex imaging data without replacing human expertise.

In a retrospective study to evaluate the effectiveness of the AI tool, six radiologists reviewed 200 CT scans, both with and without AI assistance, resulting in 2,400 individual image readings. The assessments compared diagnostic sensitivity, tumor measurement accuracy, reporting speed, and agreement between radiologists. The findings, published in Nature Communications Medicine, showed that AI assistance reduced the time required to identify, measure, and report malignant lesions by approximately one third, while maintaining diagnostic accuracy.

“This study adds to the growing body of evidence that modern AI tools developed in research labs can make a real impact in clinical practice and support doctors in their daily work,” said Associate Professor Dmytro Fishman. “We are very encouraged by these results, which show that AI research in medicine is not only meaningful, but it can truly be used for good.”

Related Links:
University of Tartu Institute of Computer Science
Better Medicine


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.